Related Experiment Video
Updated: May 15, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Update in the management of aortic dissection
Jip L Tolenaar1, Guido H W van Bogerijen, Kim A Eagle
1Thoracic Aortic Research Center, IRCCS Policlinico San Donato, Cardiovascular Center E. Malan, University of Milan, Via Morandi, 30, 20097, San Donato Milanese, MI, Italy.
Insights
Advances in acute aortic dissection (AAD) care improve outcomes. Type A AAD requires surgery, while Type B AAD is medically managed, with thoracic endovascular aortic repair (TEVAR) increasingly used for complicated cases.
Area of Science:
- Cardiovascular Surgery
- Vascular Medicine
- Medical Technology
Background:
- Acute aortic dissections (AAD) management has evolved with improved diagnosis, peri-operative care, and surgical techniques, leading to reduced mortality and morbidity.
- The traditional algorithm differentiates Type A AAD (surgical intervention) from Type B AAD (medical management), though initial medical therapy is standard for all AAD.
- Recent advancements include cerebral protection strategies and aortic valve repair in Type A AAD, and the growing role of thoracic endovascular aortic repair (TEVAR).
Purpose of the Study:
- To review current management strategies for acute aortic dissections (AAD), focusing on surgical and endovascular interventions.
- To highlight the evolving role of thoracic endovascular aortic repair (TEVAR) in both Type A and Type B aortic dissections.
- To emphasize the importance of long-term medical management and surveillance for all AAD patients.
Main Methods:
- Review of current literature and treatment algorithms for acute aortic dissections.
- Discussion of surgical techniques for Type A AAD, including cerebral protection and valve repair.
- Analysis of the application of thoracic endovascular aortic repair (TEVAR) in complicated Type B AAD and potential future uses in Type A AAD.
Main Results:
- Improved surgical techniques and peri-operative care have decreased mortality and morbidity in AAD.
- TEVAR is the primary treatment for complicated Type B AAD, effectively managing malperfusion and promoting aortic remodeling.
- Hybrid procedures combining open repair and TEVAR are used for Type A AAD involving the descending aorta, with potential for future total endovascular repair.
Conclusions:
- Management of AAD has significantly improved, with specialized surgical techniques for Type A and TEVAR for complicated Type B dissections.
- TEVAR is a crucial tool for complicated Type B AAD and shows promise for Type A AAD, potentially enabling total endovascular repair in the future.
- All patients with AAD require lifelong antihypertensive management, imaging surveillance, and clinical follow-up, regardless of initial treatment modality.
Opinion Statement:
Recent improvements in diagnosis, peri-operative management, surgical techniques and postoperative care have resulted in decreased mortality and morbidity in acute aortic dissections (AAD). The classic treatment algorithm indicates that type A patients require direct surgical intervention and type B patients should be treated medically, in absence of complications. Initial medical treatment is adopted in all AAD patients, as it reduces propagation of the dissection and aortic rupture. In type A aortic dissection (TAAD) several techniques have contributed to major changes in the surgical approach, such as cerebral protection using moderate circulatory arrest, selective cerebral perfusion, and aortic valve sparing with root replacement. In TAAD with involvement of the descending aorta, thoracic endovascular aortic repair (TEVAR) can be performed as a part of a complex hybrid procedure, in which surgical ascending/arch repair is combined with the placement of a stent graft in the descending aorta. Future developments in stent graft technologies might broaden the usefulness of TEVAR for the total endovascular repair of TAAD. In complicated type B aortic dissection (TBAD), the use of TEVAR has become the therapy of first choice. By covering the proximal entry tear, the stent graft reduces the pressurization of the false lumen, treating malperfusion and inducing favorable aortic remodeling. In uncomplicated TBAD, TEVAR has been used to prevent long term complications, such as aortic aneurysm, but this concept is not yet routinely recommended. Regardless of their initial treatment, all AAD patients should be administered with strict antihypertensive management combined with imaging surveillance and careful periodic clinical follow-up.
Related Concept Videos
Aneurysm IV: Nursing Management
Aneurysm III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction